Literature DB >> 11884051

Prognostic factors in soft tissue sarcomas: a study of 395 patients.

P D Stefanovski1, E Bidoli, A De Paoli, A Buonadonna, G Boz, M Libra, S Morassut, C Rossi, A Carbone, S Frustaci.   

Abstract

AIMS: The aim of this study was to report prognostic factors, end-points of local recurrence, distant recurrence, post-metastasis survival, and overall survival in a cohort of patients with soft tissue sarcomas.
METHODS: We analysed a database of 395 patients affected by primary soft tissue sarcomas of various primary sites, treated and followed up at the Centro di Riferimento Oncologico, Aviano, Italy from January 1985 to January 1997.
RESULTS: Grade, size, stage, surgical margins, distant metastasis, age, sex, performance status, and haemoglobin value were significant for overall survival. Histology, grade, stage, and surgical margins were significant for local recurrence. Grade, size, and stage, were significant for distant recurrence; and surgical margin was significant variable for post-metastasis survival.
CONCLUSIONS: Grade, size, and TNM stage (UICC/AJCC) have stronger prognostic significance for overall survival and distant recurrence than for local relapse. Positive surgical margins are the main predictors for local relapse. Age was the most consistent adverse independent prognostic factor for survival. Copyright Harcourt Publishers Limited.

Entities:  

Mesh:

Year:  2002        PMID: 11884051     DOI: 10.1053/ejso.2001.1242

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  32 in total

1.  Recurrent Dedifferentiated Liposarcoma Arising from the Small Bowel Mesentery: A Case Report.

Authors:  Nikolaos Panagiotopoulos; Charis Kyriakides; Ruwan A Weerakkody; Rada Ahma; Gordon Buchanan; Charles Lowdell; Long R Jiao
Journal:  J Gastrointest Cancer       Date:  2012-09

2.  Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.

Authors:  B Kasper; S Sleijfer; S Litière; S Marreaud; J Verweij; R A Hodge; S Bauer; J M Kerst; W T A van der Graaf
Journal:  Ann Oncol       Date:  2014-02-06       Impact factor: 32.976

3.  Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas.

Authors:  Matthias H M Schwarzbach; Ulf Hinz; Antonia Dimitrakopoulou-Strauss; Frank Willeke; Servando Cardona; Gunhild Mechtersheimer; Thomas Lehnert; Ludwig G Strauss; Christian Herfarth; Markus W Büchler
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

4.  Pathologic necrosis following neoadjuvant radiotherapy or chemoradiotherapy is prognostic of poor survival in soft tissue sarcoma.

Authors:  Nicholas P Gannon; Matthew H Stemm; David M King; Meena Bedi
Journal:  J Cancer Res Clin Oncol       Date:  2019-03-07       Impact factor: 4.553

5.  Peritoneal sarcomatosis: site of origin for the establishment of an in vitro and in vivo cell line model to study therapeutic resistance in dedifferentiated liposarcoma.

Authors:  Sabrina Mersch; Jasmin C Riemer; Philipp M Schlünder; Markus P Ghadimi; Hany Ashmawy; Birte Möhlendick; Stefan A Topp; Tanja Arent; Patric Kröpil; Nikolas H Stoecklein; Helmut E Gabbert; Wolfram T Knoefel; Andreas Krieg
Journal:  Tumour Biol       Date:  2015-09-15

6.  A retrospective statistical analysis of high-grade soft tissue sarcomas.

Authors:  Gregory G Kolovich; Adam N Wooldridge; Jonathan M Christy; Martha K Crist; Joel L Mayerson; Thomas J Scharschmidt
Journal:  Med Oncol       Date:  2011-05-07       Impact factor: 3.064

7.  Prognostic significance of Minichromosome maintenance protein 7 and Geminin expression in patients with 109 soft tissue sarcomas.

Authors:  Yuki Hamamoto; Kohei Shomori; Kanae Nosaka; Tomohiro Haruki; Ryota Teshima; Hisao Ito
Journal:  Oncol Lett       Date:  2010-07-01       Impact factor: 2.967

8.  Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcoma.

Authors:  Maria Serena Benassi; Laura Pazzaglia; Chiara Novello; Irene Quattrini; Serena Pollino; Giovanna Magagnoli; Piero Picci; Amalia Conti
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

9.  Multimodality treatment of locally advanced soft-tissue sarcomas of the extremities.

Authors:  Vincenzo Ravo; Immacolata Marrone; Anna Morra; Roberto Manzo; Paola Murino; Fabrizio Cammarota; Paolo Muto
Journal:  Rep Pract Oncol Radiother       Date:  2010-10-06

Review 10.  Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy.

Authors:  John Charlson
Journal:  Curr Treat Options Oncol       Date:  2018-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.